Shilajit Science: What Human Evidence Actually Shows
Shilajit marketing is full of confident claims. It boosts testosterone, fights fatigue, sharpens memory, slows ageing. Some of this traces back to real, peer reviewed research. Much of it does not. This article works through what has actually been published, graded honestly by evidence type, with sample sizes, funding sources and limitations stated plainly, so you can tell the difference between a real study and a claim that simply gets repeated often enough to sound like one.
In this article
Key takeaways
- One real, placebo controlled human trial supports a testosterone rise in healthy men. It has not been independently replicated.
- Memory, cognition and anti-ageing claims are not supported by any verified human study we could locate.
- The clearest, best documented issue is safety, not efficacy: heavy metal risk in unpurified resin, and a roughly 32,000 per cent spread in fulvic acid content across commercial products tested.
How to read the evidence grades used here
- Systematic review a structured summary of multiple studies on a topic. The strongest single evidence type here, though only as strong as the studies it includes.
- Human RCT a randomised, controlled trial in people. Meaningful evidence, but one small trial is not the same as a well replicated finding.
- Human pilot tested in people, but without a placebo comparison group, which makes it hard to rule out placebo effect, natural fluctuation, or bias.
- Animal study tested in animals, usually rats or mice. Useful for understanding mechanisms, but it does not establish a human effect.
- In vitro tested in a lab dish or on isolated cells or compounds. The earliest and most preliminary evidence type.
- Traditional use a historical or cultural use claim, not a scientific finding.
- No evidence found we searched for this claim directly and could not locate anything real or verifiable.
Testosterone and male vitality: the most over claimed area, examined directly
This is worth taking seriously precisely because it is the most commercially exploited claim, and because, unusually for this category, there is a real study behind it.
In 2016, Pandit and colleagues published a randomised, double blind, placebo controlled human trial in the journal Andrologia. Healthy men aged 45 to 55 took purified shilajit at 250mg twice daily for 90 days. The trial reported statistically significant increases in total testosterone, roughly 20 per cent, along with free testosterone and DHEAS, compared with placebo, and no serious adverse events.
What marketing usually leaves out is worth spelling out plainly. The men in this trial were already healthy, not diagnosed with low testosterone, so a 20 per cent rise from a normal baseline is a different claim to "restores low testosterone." The finding has not been independently replicated by an unconnected research group. And no symptomatic outcome such as libido, energy or mood was reported alongside the hormone numbers, so it is genuinely unclear whether the hormonal change was felt by the men involved.
A second, related trial by Biswas and colleagues in 2010 reported improved sperm count, motility and testosterone in men with low sperm counts after 90 days. This one appears to have used a before and after design without a placebo group, which is a meaningfully weaker design. Without a comparison arm, it is hard to rule out ordinary fluctuation over a 90 day period.
On erectile function specifically, we found no human trial demonstrating that shilajit improves it. This is a common marketing claim that is not supported by the evidence we could locate.
Energy and fatigue: mostly mechanistic, with one important funding caveat
A human pilot study by Das and colleagues in 2016 examined muscle gene expression in 16 overweight adults given a branded, purified shilajit extract (PrimaVie) for 12 weeks. It found changes in genes related to muscle tissue repair, a real and measurable result, but a gene expression change is not the same as a reported increase in felt energy, and the study had no placebo comparison. It was also funded in part by Natreon, the manufacturer of the branded extract used, which is worth knowing when weighing how much confidence to place in it.
A separate placebo controlled trial in 63 young, fit men, published by Keller and colleagues in 2019, found the same branded extract helped preserve muscle strength after a fatigue protocol. This was tested in young athletic men, though, not the tired, older or run down population shilajit is usually marketed to.
The popular claim that shilajit boosts CoQ10 and mitochondrial energy traces back to a single mouse study published in a minor journal. It is a real result, in mice, not established human science.
Bottom line: plausible mechanistic and animal support exists. The human evidence is limited to a small, manufacturer funded gene expression study and one trial in young athletes, which is not the same as demonstrating that shilajit reduces everyday fatigue in the people who most often buy it.
Cognition and memory: the weakest claim category
We looked specifically for a human trial supporting memory or cognitive benefits and could not verify one. A frequently repeated claim, describing a 90 day trial in adults aged 45 to 70 with improved memory and attention, could not be traced to any real author, journal, or study identifier. It has the hallmarks of a marketing claim repeated so often that it now sounds like a citation. We would treat it as unverified rather than as evidence.
What is real is laboratory research showing that fulvic acid can stop a protein called tau from clumping together in a test tube, a process relevant to Alzheimer's research. That is genuine, interesting biochemistry. It is also several steps removed from showing that shilajit improves memory in a living person, let alone that it treats or prevents dementia, a claim we are not making and would caution strongly against.
Anti-ageing and longevity: mechanistic speculation, not demonstrated benefit
Claims that shilajit activates longevity genes or increases cellular energy in ageing cells extrapolate from the same animal and in vitro antioxidant research discussed above. They do not reflect any human study on ageing or lifespan. We found no human trial measuring biological age, longevity markers, or lifespan in shilajit users. There is a real, though disease specific, human trial in elderly patients with high blood pressure examining oxidative stress and blood vessel function, a genuinely relevant vascular health data point, but not the same thing as a general anti-ageing effect, and we were unable to independently verify its detailed results.
Safety and heavy metals: the most important section for a buyer
This is the one area where the evidence is both clearest and most commercially relevant. Shilajit forms in mineral rich rock, which means raw, unpurified resin can carry the same heavy metals present in its geological source. Lead, arsenic, mercury and others are repeatedly documented in the scientific literature on this topic, including real case reports of lead poisoning linked to unpurified, informally sold products.
This is exactly why purification and independent, batch specific testing matter, not as a marketing phrase but as the direct answer to a real, documented risk. A 2024 independent testing report from ConsumerLab looked at eight commercial shilajit products and found heavy metals within acceptable limits across all eight, but also found a spread of roughly 32,000 per cent in actual fulvic acid content between products. In practical terms, "shilajit" as a labelled category covers an enormous quality range, even among established brands.
See our companion article, How to Spot Fake Shilajit, for what independent lab testing can and cannot establish, and ShilNepal's own current batch report as a worked example.
Evidence strength, visualised
The chart below plots the strongest evidence tier actually reached for each major claim area discussed above, drawn directly from the summary table further down this page. It is not a ranking of how popular a claim is, only of how far the real evidence behind it goes.
Is there an overall systematic review?
Not a large, rigorous one. The closest is a 2024 systematic review by Ali and colleagues, published in the Journal of Population Therapeutics and Clinical Pharmacology, covering a small number of human trials across fatigue, reproductive health, high altitude sickness, and cognitive function. Its own conclusion is that results are promising, but the underlying studies are small, and more rigorous research is needed before any clinical claim is warranted. A separate 2026 systematic review looking specifically at cancer related research found only preclinical, lab and animal, evidence, with no eligible human studies at all, which is a useful, direct check against any cancer related claim.
Evidence summary table
| Claim area | Strongest evidence found | Human evidence? | Key caveat |
|---|---|---|---|
| Testosterone (healthy men) | Human RCT Pandit 2016 | Yes, one trial | Unreplicated, healthy population, no symptom data |
| Sperm count and motility | Human pilot Biswas 2010 | Yes, likely uncontrolled | No clear placebo arm, small completer sample |
| Erectile function | None found | No evidence found | Common marketing claim, not supported |
| Energy and muscle (gene expression) | Human pilot Das 2016 | Yes, no placebo | Manufacturer funded, measures gene expression, not felt energy |
| Muscle strength and fatigue | Human RCT Keller 2019 | Yes, one trial | Tested in young athletic men only |
| Memory and cognition | In vitro only | No verified human evidence | Widely repeated "90 day memory trial" claim could not be verified as real |
| Anti-ageing and longevity | Animal & in vitro | No verified human evidence | Mechanistic extrapolation, not demonstrated |
| Cancer | Systematic review (preclinical) | No human studies eligible | Explicitly no clinical evidence per the review itself |
| Heavy metal safety | Case reports and product testing | Yes, documented risk | Purification and independent testing are the real answer, not a marketing phrase |
What this means for a buyer
Shilajit has more real, peer reviewed human research behind it than many supplement ingredients, and that is a fair, honest statement to make. It is equally true that the strongest human evidence, on testosterone, rests on one unreplicated trial, that cognition and anti-ageing claims are not supported by verifiable human data, and that the most concrete, well documented issue is a safety one. Heavy metal content varies by sourcing and purification quality, which is precisely why independent batch testing matters more than any efficacy claim on a label.
This article does not make, and should not be read as making, any claim that ShilNepal's product treats, prevents or cures any condition. It is not TGA approved, ARTG registered, or medically proven, and nothing here is a substitute for advice from a qualified health professional.
FAQ
Is there real scientific evidence for shilajit?
Yes. Several small human trials exist, particularly around testosterone in healthy men and muscle related outcomes. The evidence is real but limited: small samples, largely unreplicated, and in some cases funded by ingredient manufacturers.
Does shilajit definitely increase testosterone?
One placebo controlled human trial found a significant increase in healthy men aged 45 to 55. It has not been independently replicated, and no symptom level outcome, such as libido, was measured alongside the hormone change.
Is shilajit proven to improve memory?
No. We could not verify any real human study supporting a memory claim. The evidence here is limited to laboratory biochemistry.
What is the biggest real safety consideration?
Heavy metal content in unpurified or poorly sourced raw resin, which is a documented risk in the scientific literature, including real poisoning case reports. This is why independent, batch specific lab testing matters.
References
- Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570 to 575. DOI: 10.1111/and.12482
- Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48 to 56. PMID: 20078516
- Das A, Datta S, Rhea B, et al. The Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation. Journal of Medicinal Food. 2016;19(7):701 to 709.
- Keller JL, Housh TJ, Hill EC, et al. The effects of Shilajit supplementation on fatigue induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition. 2019;16(1):3.
- Carrasco-Gallardo C, Guzman L, Maccioni RB. Shilajit: A Natural Phytocomplex with Potential Procognitive Activity. International Journal of Alzheimer's Disease. 2012;2012:674142.
- Ali SM, Iqbal N, Ishaq W, et al. Systematic Review of Shilajit: Clinical Efficacy and Safety. Journal of Population Therapeutics and Clinical Pharmacology. 2024;31(6):1464 to 1471.
- Hussain et al. Hazardous or Advantageous: Uncovering the Roles of Heavy Metals and Humic Substances in Shilajit. Biological Trace Element Research. 2024.
- ConsumerLab.com. Shilajit Supplements Found to Contain High Amounts of Fulvic Acid (product testing report). September 2024.
Some sources above were verified via full text, others via abstract or converging secondary reporting where publisher access was blocked, noted transparently in our internal research record. Where a specific number could not be independently confirmed, we have either left it out or flagged it as unverified rather than repeat it as fact.
Further claim-area reviews
The claim areas above are the ones with the most marketing weight behind them. These carry the same evidence-graded treatment:
